WASHINGTON — The scion of an Indian pharmaceutical family claims to have crafted a liver-friendly vodka — and wants to tout that health benefit on the bottle.
But does it work? And, if so, would the US officials who regulate the alcohol industry permit a company to make such a claim?
The entrepreneur behind the spirits is Harsha Chigurupati, whose relatives are majority owners of Granules India, a major supplier of acetaminophen, ibuprofen, and other drugs.
